Treatment Clinical Trials for Multiple Myeloma/Plasma Cell Myeloma

Clinical Trial Finder Tool - Multiple Myeloma Research Foundation

The RAPA-201-RRMM study is a clinical trial that investigates the use of autologous T cells in adults with relapsed and refractory multiple myeloma who have ...

The clinical trials on this list are for multiple myeloma/plasma cell myeloma treatment. All trials on the list are NCI-supported clinical trials.

Multiple Myeloma Clinical Trials & Research

MSK tests new treatments for multiple myeloma. In general, treatment trials test new drugs, drug combinations, devices, and ways of doing procedures, surgery, ...

Multiple Myeloma Clinical Trials - Mayo Clinic Research

Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving lenalidomide and ixazomib together may work better ...

Multiple Myeloma Clinical Trials | Pfizer

Pfizer is studying a potential treatment for multiple myeloma that uses a person's immune system to fight off cancer cells.

Clinical Trials and Emerging Therapies for Multiple Myeloma

All of the drugs being investigated in MyDRUG℠ have already been FDA-approved to treat other types of cancer, but their effectiveness in patients with multiple ...

Multiple Myeloma Clinical Trials - Moffitt Cancer Center

Drug therapies to control myeloma or alleviate symptoms · Stem cell transplants used in combination with high-dose chemotherapy · Bisphosphonates for treating ...

Multiple Myeloma Clinical Trials - SparkCures

The path towards newer, better therapies and one day a cure for myeloma, is through clinical trials. Yet, less than 1 out of every 10 myeloma patients will ever ...

Clinical Trials for Multiple Myeloma - Siteman Cancer Center

At Siteman Cancer Center, research is essential to improving patient care. Find clinical trials & clinical studies offered for multiple myeloma.

Find a Clinical Trial | Mount Sinai - New York

The purpose of this study is to provide ongoing access to study treatments for participants with multiple myeloma or smoldering multiple myeloma benefiting from ...

Protocol Details - NIH Clinical Studies

These two drugs are an approved treatment for multiple myeloma that has not responded to at least one other treatment. Carfilzomib is an experimental drug that ...

Research and Clinical Trials | Myeloma Center

The patients and team at the Myeloma Center are involved in a number of clinical trials to help advance the field so that the goal of finding a cure for ...

Plasma Cell Disorders Clinical Trials - Mayo Clinic Research

This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...

Immunotherapy for Multiple Myeloma - Cancer Research Institute

Immunotherapy is class of treatments that take advantage of a person's own immune system to help kill cancer cells. There are currently five FDA-approved ...

Multiple Myeloma and Gammopathies Program - Yale Medicine

... multiple myeloma, a cancer of a type of white blood cell, or plasma cell ... clinical trials in the field continue to provide patients with new options for care.

Clinical Trials Using Bortezomib - NCI

This phase II trial tests whether isatuximab, lenalidomide, bortezomib, and dexamethasone works in treating patients with newly diagnosed multiple myeloma.

Treatment Options for Multiple Myeloma and Other Plasma Cell ...

People with high-risk myeloma are more likely to get a 4-drug regimen for their induction treatment. After several months of this, stem cells ...

Multiple Myeloma Clinical Research | OSUCCC – James

Phase I Study Shows Antibody as Safe and Effective in Multiple Myeloma Treatment. Natural killer (NK) cells in the body's immune system work to destroy multiple ...

Multiple Myeloma Clinical Trials

Find recruiting clinical trials offered for Multiple Myeloma at BMS Clinical Trials. Take our pre-screener today to see if you are eligible for the study.

Multiple Myeloma Clinical Trials - Rogel Cancer Center

Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...